ExpressionEdits
PrivateLast Round
Seed
May 29, 2024
Total Funding Raised
$13M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
ExpressionEdits operates in Healthcare & Life Sciences and is based in Cambridge. Its latest recorded funding round was a Seed round in May 2024.
ExpressionEdits is a biotechnology company that offers a research platform aimed at enhancing transgene expression in mammalian systems to improve recombinant protein yields and the efficacy of DNA medicines.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ExpressionEdits Comparables
Compare ExpressionEdits with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Proteinea | 72% | |
| Ginkgo Bioworks | 71% | |
| ATUM | 67% |
For institutional investors. Book with your work email.
ExpressionEdits Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
ExpressionEdits Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BlueYard Capital | Seed |
| Acequia Capital | Seed |
| Amino Collective | Seed |
| Hawktail Management | Seed |
| Redalpine | Seed |
| Octopus Ventures | Seed |
| Wilbe Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 221% MoM, reaching 1.5K.
- Feb 12, 2025
Partnering to develop enhanced gene therapies.
For institutional investors. Book with your work email.
ExpressionEdits Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about ExpressionEdits's valuation, stock price, and market status.
Is ExpressionEdits a public or private company?
ExpressionEdits is a private company.
What is the current stock price of ExpressionEdits?
ExpressionEdits is a private company, so its shares have no public market price. Caplight tracks ExpressionEdits's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is ExpressionEdits worth (valuation)?
Valuation information for ExpressionEdits is not publicly available.
Can I buy ExpressionEdits stock?
ExpressionEdits shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was ExpressionEdits's last funding round?
ExpressionEdits's most recent funding round was Seed on May 29, 2024.
Who are the main investors in ExpressionEdits?
Key investors in ExpressionEdits include Redalpine, Octopus Ventures.
Will ExpressionEdits IPO soon?
No public IPO plans have been announced for ExpressionEdits.
How can I track ExpressionEdits secondary market activity?
Caplight tracks bids, offers, and trades in ExpressionEdits's shares on secondary markets.